Pregnancy

Zomedica Expands TRUFORMA(R) Diagnostic Menu with Launch of Equine Progesterone Assay

Newest assay expands TRUFORMA market opportunity by building on endocrinology foundation to address reproductive health in the equine segment ANN…

1 day ago

10 Ways to Geek Out on FSA-eligible High-tech Health from FSA Store® and Spend Tax-free Funds Before the December 31 Flexible Spending Account (FSA) Deadline

From trending products like light therapy devices, baby health monitors, and wearable diagnostic trackers, use FSA funds to gift health…

3 days ago

What is a “Mommy Makeover” and Who is It For? Dr. Ember Ewings Shares Her Perspective

Dr. Ember Ewings provides insight into modern mommy makeover planning, emphasizing personalized treatment, realistic expectations, and long-term results for patients…

4 days ago

Daré Bioscience Announces Return of Rights to Ovaprene®; Phase 3 Program Ongoing; Positive Interim Data and Grant Funding Position Asset for Value-Maximization

SAN DIEGO, Dec. 01, 2025 (GLOBE NEWSWIRE) --  Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused…

4 days ago

GE HealthCare builds on a century of innovation to shape the future of radiology at RSNA 2025

The company will showcase a wave of transformative innovations designed to address the most pressing challenges in healthcare, spanning the…

5 days ago

KOMZIFTI™ (ziftomenib) Added to National Comprehensive Cancer Network® (NCCN) Guidelines for Acute Myeloid Leukemia (AML)

KOMZIFTI, the first and only once-daily FDA-approved menin inhibitor for R/R NPM1-mutated AML, is now commercially available in the United…

1 week ago

Sera Announces Publication Acceptance for PRIME Study

The PRIME study, one of the largest studies on preterm birth, has been accepted for publication by a medical journal…

2 weeks ago

Daré Bioscience Receives $3.6 Million in Additional Grant Funding

Grant funding will support continued progress on a preclinical research program to identify and develop a non-hormonal intravaginal contraceptive innovation…

2 weeks ago

Dionysus Health Appoints Digital Health Leader Rashmi Raghavendra as Chief Executive Officer

New CEO to Lead Company from Groundbreaking Science to Commercial Launch in Maternal Mental Health DiagnosticsSEATTLE, Nov. 22, 2025 /PRNewswire/…

2 weeks ago

Citius Oncology to Advance Commercial Launch of LYMPHIR™ with Verix AI Integration

Leading edge artificial intelligence and machine learning platform supports enhanced salesforce targeting and engagement for cutaneous T-cell lymphoma immunotherapy launchCRANFORD,…

2 weeks ago